Overview Dividends

(SPNS) Sapiens International - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: KYG7T16G1039

Insurance, Software, Platform, Consultancy, Reinsurance

Application Software
Market Cap in USD: 2,429m

IPO / Inception: 1992-05-29
Return 12m vs S&P 500: -13.9%

EPS (Earnings per Share)

EPS CAGR: 3.19%
EPS Trend: 79.1%

Last SUE: 0.89
Qual. Beats: 4

Revenue

Rev. CAGR: 6.75%
Rev. Trend: 95.6%

Last SUE: 2.85
Qual. Beats: 2

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	70.0%
Value at Risk 5%th	61.8%
Relative Tail Risk	-46.35%

Reward TTM
Sharpe Ratio	1.42
Alpha	58.86
CAGR/Max DD	8.51

Character TTM
Hurst Exponent	0.086
Beta	-4.762
Beta Downside	9.990

Drawdowns 3y
Max DD	99.69%
Mean DD	11.98%
Median DD	7.88%

Description: SPNS Sapiens International November 13, 2025

Sapiens International Corp. (NASDAQ: SPNS) develops and sells cloud-native software for insurers across property-and-casualty, life & pensions, and reinsurance markets in North America, Europe and beyond. Its flagship offerings include IDIT Suite (AI-driven end-to-end processing), Digital Suite (customer-facing engagement), Core Suite (policy administration), CustomerConnect/AgentConnect portals, and ReinsuranceMaster for automated reinsurance workflow.

In FY 2023 the company generated $618 million in revenue, with subscription-based ARR expanding at roughly 20% YoY and subscription revenue now representing about 70% of total sales-metrics that underscore the shift toward recurring-revenue models in insurance tech. Growth is being propelled by macro-level drivers such as accelerated digital transformation in the insurance sector (projected 13% CAGR for cloud adoption through 2029) and heightened regulatory pressure for real-time data analytics, both of which favor AI-enabled platforms like Sapiens.

For a deeper, data-driven valuation perspective, you may find ValueRay’s analyst platform worth exploring.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (64.3m TTM) > 0 and > 6% of Revenue (6% = 33.9m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -0.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 15.19% (prev 32.30%; Δ -17.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.11 (>3.0%) and CFO 80.0m > Net Income 64.3m (YES >=105%, WARN >=100%)

Net Debt (-38.7m) to EBITDA (93.5m) ratio: -0.41 <= 3.0 (WARN <= 3.5)

Current Ratio 1.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (56.4m) change vs 12m ago 0.22% (target <= -2.0% for YES)

Gross Margin 44.30% (prev 43.40%; Δ 0.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 79.09% (prev 78.87%; Δ 0.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 196.1 (EBITDA TTM 93.5m / Interest Expense TTM 395.0k) >= 6 (WARN >= 3)

Altman Z'' 4.68

(A) 0.12 = (Total Current Assets 251.8m - Total Current Liabilities 166.0m) / Total Assets 743.7m

(B) 0.22 = Retained Earnings (Balance) 160.2m / Total Assets 743.7m

(D) 2.37 = Book Value of Equity 513.5m / Total Liabilities 216.5m

Total Rating: 4.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 86.92

1. Piotroski 7.50pt

2. FCF Yield 3.01%

3. FCF Margin 12.77%

4. Debt/Equity 0.08

5. Debt/Ebitda -0.41

6. ROIC - WACC (= 23.38)%

7. RoE 13.18%

8. Rev. Trend 95.55%

9. EPS Trend 79.13%

What is the price of SPNS shares?

As of December 28, 2025, the stock is trading at USD 13950.00 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.00%, over three months by +0.00% and over the past year by +0.00%.

Is SPNS a buy, sell or hold?

Sapiens International has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold SPNS.

Strong Buy: 0
Buy: 1
Hold: 2
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the SPNS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	37.3	-99.7%
Analysts Target Price	37.3	-99.7%
ValueRay Target Price	16213	16.2%

SPNS Fundamental Data Overview December 23, 2025

Market Cap USD = 2.43b (2.43b USD * 1.0 USD.USD)
P/E Trailing = 37.7826
P/E Forward = 29.5858
P/S = 4.304
P/B = 4.7303
P/EG = 5.9208
Beta = 0.901
Revenue TTM = 564.3m USD
EBIT TTM = 77.5m USD
EBITDA TTM = 93.5m USD
Long Term Debt = 19.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 26.2m USD (from shortTermDebt, last quarter)
Debt = 43.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -38.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.39b USD (2.43b + Debt 43.5m - CCE 82.2m)
Interest Coverage Ratio = 196.1 (Ebit TTM 77.5m / Interest Expense TTM 395.0k)
FCF Yield = 3.01% (FCF TTM 72.1m / Enterprise Value 2.39b)
FCF Margin = 12.77% (FCF TTM 72.1m / Revenue TTM 564.3m)
Net Margin = 11.40% (Net Income TTM 64.3m / Revenue TTM 564.3m)
Gross Margin = 44.30% ((Revenue TTM 564.3m - Cost of Revenue TTM 314.3m) / Revenue TTM)
Gross Margin QoQ = 44.19% (prev 43.71%)
Tobins Q-Ratio = 3.21 (Enterprise Value 2.39b / Total Assets 743.7m)
Interest Expense / Debt = 0.91% (Interest Expense 395.0k / Debt 43.5m)
Taxrate = 20.12% (3.62m / 18.0m)
NOPAT = 61.9m (EBIT 77.5m * (1 - 20.12%))
Current Ratio = 1.52 (Total Current Assets 251.8m / Total Current Liabilities 166.0m)
Debt / Equity = 0.08 (Debt 43.5m / totalStockholderEquity, last quarter 513.5m)
Debt / EBITDA = -0.41 (Net Debt -38.7m / EBITDA 93.5m)
Debt / FCF = -0.54 (Net Debt -38.7m / FCF TTM 72.1m)
Total Stockholder Equity = 488.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.65% (Net Income 64.3m / Total Assets 743.7m)
RoE = 13.18% (Net Income TTM 64.3m / Total Stockholder Equity 488.0m)
RoCE = 15.25% (EBIT 77.5m / Capital Employed (Equity 488.0m + L.T.Debt 19.8m))
RoIC = 12.07% (NOPAT 61.9m / Invested Capital 512.7m)
WACC = -11.31% (negative - check inputs) (E(2.43b)/V(2.47b) * Re(-11.53%) + D(43.5m)/V(2.47b) * Rd(0.91%) * (1-Tc(0.20)))
Discount Rate = 9.70% (= Risk Free + ERP)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 73.92% ; FCFE base≈71.6m ; Y1≈78.1m ; Y5≈98.6m
Fair Price DCF = 23.09 (DCF Value 1.29b / Shares Outstanding 55.9m; 5y FCF grow 10.35% → 3.0% )
EPS Correlation: 79.13 | EPS CAGR: 3.19% | SUE: 0.89 | # QB: 4
Revenue Correlation: 95.55 | Revenue CAGR: 6.75% | SUE: 2.85 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=-0.021 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.54 | Chg30d=-0.007 | Revisions Net=+1 | Growth EPS=+7.3% | Growth Revenue=+7.0%

Additional Sources for SPNS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle